Associations of SHR with all-cause mortality. by Heshan Cao (17967095)

Subjects:

RCS of the relationship between GNRI and all-cause mortality in PAD patients. by Zhe Wu (582498)

Subjects:

Identification test and cause analysis. by Wei Wang (17594)

Identification test and cause analysis. by Wei Wang (17594)

Overexpression of Gαq decreases cell number and cell size. by Dharsan K. Soundarrajan (11632145)

Rates for the composite EP consisted of all-cause mortality, stroke, major bleedings and MI increased as eGFR declined. by Christian Salbach (10170370)

Independent association of social determinants of health and cardiovascular health with all-cause and cause-specific mortality. by Boxuan Pu (19987285)

Combined associations of social determinants of health and cardiovascular health with all-cause and cause-specific mortality. by Boxuan Pu (19987285)

A possible cause of epistaxis: increased masked hypertension prevalence in patients with epistaxis by Baran Acar (10419356)

“…Conclusion This study demonstrates increased masked hypertension prevalence in patients with epistaxis. …”

Proportion of ACSC by groups of causes, considering the five most frequent causes. by Isabelle Aguiar Prado (12850436)

Details of the damage caused by large-scale earthquakes. by Yuta Inoue (2404879)

Key index threshold values of slope instability caused by continuous rainfall intensity. by Li Ronghua (8034416)

Decrease of cellular cAMP levels in response to a concentration range of melatonin treatments. by Cathryn S. D. Maienza (20629929)

Mediation of cardiovascular health on the associations between social determinants of health and all-cause and cause-specific mortality. by Boxuan Pu (19987285)

Drosophila homologs of mammalian ATF4 target genes with significantly increased expression in ND-75^KD flies. by Lucy Granat (5570813)

Association of SHR and the risk of all-cause mortality. by Heshan Cao (17967095)

Subjects:

Table1_One year of treatment with elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis homozygous for the F508del mutation causes a significant increase in liver biochemical indexes.docx by Alice Castaldo (9956004)

“…</p><p>Results: Beyond the improvement of BMI and lung function with LI treatment and even more with ETI, we found that the 3 years of LI treatment significantly improved liver function parameters (total and conjugated bilirubin, ALT, AP, and GGT), while the subsequent ETI treatment caused a significant increase of such parameters.…”

Table2_One year of treatment with elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis homozygous for the F508del mutation causes a significant increase in liver biochemical indexes.docx by Alice Castaldo (9956004)

“…</p><p>Results: Beyond the improvement of BMI and lung function with LI treatment and even more with ETI, we found that the 3 years of LI treatment significantly improved liver function parameters (total and conjugated bilirubin, ALT, AP, and GGT), while the subsequent ETI treatment caused a significant increase of such parameters.…”

Kaplan-Meier survival probability and cumulative hazard for cause-diseases of heart mortality (A), cause-malignant neoplasms mortality (B), and cause-all other causes mortality (C)... by Yan Wang (15435)

Subjects:

Results of GO analysis showing significantly enriched biological process (BP), cellular component (CC) and molecular function (MF) in genes with significantly increased expression... by Lucy Granat (5570813)